Red Tree Venture Capital
Redwood City, Californiaredtreevc.com
Overview
Red Tree Venture Capital is an early stage-biased life science venture firm that employs a targeted strategy of leveraging its deep relationships with leading West Coast academic and research institutions to source innovation emerging from those organizations . The firm focuses primarily on entrepreneurs developing first-in-class and/or best-in-class therapeutics addressing significant unmet needs in the areas of oncology, neurology, and immunology .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Excellergy | Oct 2025 | Series A | Co-investor |
| Magnus Medical | May 2025 | Series B | Co-investor |
| Kivu Biosciences | Oct 2024 | Series A | Co-investor |
| Engrail Therapeutics | Mar 2024 | Series B | Co-investor |
| Bicara Therapeutics | Dec 2023 | Series C | Co-investor |
Key People
Cassie Lue
Vice President Of Investor Relations
Jeremy Caldwell
Partner, Red Tree Venture Capital
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
